ロード中...
Outcomes of Patients on Dual-Boosted PI Regimens: Experience of the Swiss HIV Cohort Study
Dual-boosted protease inhibitors (DBPI) are an option for salvage therapy for HIV-1 resistant patients. Patients receiving a DBPI in the Swiss HIV Cohort Study between January1996 and March 2007 were studied. Outcomes of interest were viral suppression at 24 weeks. 295 patients (72.5%) were on DBPI...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc.
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2976639/ https://ncbi.nlm.nih.gov/pubmed/20929393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0070 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|